Amgen, AstraZeneca say experimental asthma drug meets trial goal ...Middle East

Yahoo - News
Amgen, AstraZeneca say experimental asthma drug meets trial goal
The partners said that the year-long trial met its primary goal in patients with severe asthma who were also receiving standard care, including medium- or high-dose inhaled corticosteroids plus at least one other controller medication. The drug was also shown to work in a subgroup of patients with low levels of a type of white blood cell, called eosinophil, associated with swelling and narrowing of airways, the drugmakers said in a press release. "The key thing is that tezepelumab also seems to work in the low eosinophil patient group, which could help it differentiate from Regeneron's Dupixent and AstraZeneca's Fasenra, both of which are indicated for the 'eosinphilic phenotype'," Mizuho

Hence then, the article about amgen astrazeneca say experimental asthma drug meets trial goal was published today ( ) and is available on Yahoo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Amgen, AstraZeneca say experimental asthma drug meets trial goal )

Apple Storegoogle play

Last updated :

Also on site :



Latest News